Baseline Characteristics
| Baseline variable | n | Percentage |
| Age (y) | 23 | 100 |
| <60 | 9 | 39 |
| ≥60 | 14 | 61 |
| Performance status | ||
| ECOG 0–1 | 18 | 79 |
| ECOG 2 | 5 | 21 |
| Tumor type | ||
| Pancreatic NET | 14 | 61 |
| Nonpancreatic NET | 9 | 39 |
| Previous treatment | ||
| Chemotherapy | 8 | 35 |
| Liver resection | 4 | 17 |
| TACE/RFA | 3 | 13 |
| PRRT | ||
| >30 GBq of 177Lu-octreotate | 13 | 57 |
| <30 GBq of 177Lu-octreotate | 10 | 43 |
| Hepatic tumor load | ||
| <25% liver volume | 3 | 13 |
| 25%–50% | 9 | 39 |
| >50% liver volume | 11 | 48 |
| Extrahepatic disease | ||
| Present | 14 | 61 |
| Not present | 9 | 39 |
| Hormonal syndrome | ||
| Functional disease | 5 | 22 |
| Nonfunctional disease | 18 | 78 |
| Proliferation status | ||
| Ki-67 index ≤ 5% | 16 | 70 |
| Ki-67 index > 5% | 7 | 30 |
Mean age was 58 y, and age range was 34–80 y.
ECOG = Eastern Cooperative Oncology Group; TACE = transarterial chemoembolization; RFA = radiofrequency ablation.